Diclofenac Potassium NDC 60290-061

NDC codes

FDA NDC Directory

Product NDC (as listed)60290-061Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60290-0061Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60290-061-01	60290006101	1 POWDER, FOR SOLUTION in 1 PACKET (60290-061-01)Marketed from Feb 15, 2026
60290-061-02	60290006102	9 POWDER, FOR SOLUTION in 1 CARTON (60290-061-02)Marketed from Feb 15, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Diclofenac Potassium
Generic name (nonproprietary): diclofenac potassium
Active ingredients: Diclofenac potassium — 50 mg/1
Dosage form: Powder, For solution
Route: Oral
Labeler: Umedica Laboratories USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217010
Marketing start: Feb 15, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)Decreased Prostaglandin Production (Physiologic effect)
Identifiers: Product ID 60290-061_499a21c5-f2cf-9987-e063-6294a90a79fbSPL ID 499a21c5-f2cf-9987-e063-6294a90a79fbSPL set ID 33930285-dd97-415c-9e2a-491bd7b12af9RxCUI 859063UNII L4D5UA6CB4
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460290006101 followed by a unit qualifier and the quantity

Package 60290-0061-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 30, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

1. INDICATIONS AND USAGE Diclofenac potassium for oral solution is indicated for the acute treatment of migraine attacks with or without aura in adults (18 years of age or older). Limitations of Use: Diclofenac potassium for oral solution is not indicated for the prophylactic therapy of migraine. The safety and effectiveness of diclofenac potassium for oral solution have not been established for cluster headache, which is present in an older, predominantly male population. Diclofenac potassium for oral solution is a non-steroidal anti-inflammatory drug (NSAID) indicated for the acute treatment of migraine attacks with or without aura in adults 18 years of age or older ( 1 ) Limitations of Us…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 217010

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217010
Product	Strength	Form · route	Labeler	Product NDC
Diclofenac Potassium	Diclofenac potassium 50 mg/1	Powder, For solutionOral	Nivagen Pharmaceuticals, Inc.	75834-338